{"id":627993,"date":"2024-04-30T14:51:51","date_gmt":"2024-04-30T18:51:51","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=627993"},"modified":"2024-10-25T09:59:14","modified_gmt":"2024-10-25T13:59:14","slug":"saxenda-vs-wegovy-price","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/saxenda-vs-wegovy-price\/","title":{"rendered":"Saxenda vs. Wegovy price comparison"},"content":{"rendered":"

Saxenda<\/span><\/a> (liraglutide) and <\/span>Wegovy<\/span><\/a> (semaglutide) are weight-loss medications approved by the Food and Drug Administration (FDA). Wegovy can also lower the risk of cardiovascular death, heart attack, and stroke in people with cardiovascular disease who either have obesity or are overweight. Both medications regulate appetite and increase feelings of fullness to promote weight loss. <\/span><\/p>\n

Saxenda<\/span><\/a> requires daily injections, while Wegovy requires weekly injections. According to a clinical trial published in <\/span>JAMA<\/span><\/i> in 2022, <\/span>Wegovy yields more than double the average weight loss of Saxenda<\/span><\/a>. Below, we’ll explain Saxenda and Wegovy distinctions, prices, discounts, and more.<\/span><\/p>\n

Saxenda vs. Wegovy: Price and insurance coverage<\/b><\/h2>\n

Without insurance, a monthly supply of Saxenda is typically around $1,802 per<\/span><\/p>\n

5, 3 mL of 18 mg\/3 mL pen injector (about 30 days, depending on your dosage schedule). During the first four weeks, you’ll gradually <\/span>increase your dosage<\/span><\/a> until you get to a maintenance dose of 3 mg daily. One pre-filled injection pen lasts six days on the maintenance dose, and a pack of five pens lasts 30 days.<\/span><\/p>\n

Wegovy is similar in cost, with a typical cash price of $1,834.52 per four, 0.75 mL of 2.4 mg\/0.75 mL pen-injector without insurance or discounts. <\/span><\/p>\n

Saxenda and Wegovy aren’t typically covered by Medicare prescription plans for weight loss, similar to many weight-loss medications. However, on March 8, <\/span>the FDA announced<\/span><\/a> that it had approved a new indication for Wegovy—for reducing the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease who either have obesity or are overweight. Since it is the first weight loss medication to be approved for this indication, it is yet to be seen whether insurance companies and federal and state governments will change their stance on coverage of weight loss medications. <\/span><\/p>\n

General insurance coverage varies widely for weight loss drugs. Although Novo Nordisk has online tools that allow you to <\/span>check your cost and coverage for Saxenda<\/span><\/a> and <\/span>Wegovy<\/span><\/a>, contacting your health insurance company may give you a more accurate idea of what you can expect to pay. <\/span><\/p>\n

RELATED: <\/b>How to get Wegovy covered by insurance<\/b><\/a><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n
\n

Saxenda vs. Wegovy cost and insurance comparison<\/span><\/h3>\n<\/th>\n<\/tr>\n<\/thead>\n

<\/td>\nSaxenda<\/b><\/td>\nWegovy<\/b><\/td>\n<\/tr>\n
Typically covered by insurance?<\/b><\/td>\nVaries by plan<\/span><\/td>\nMaybe, depending on the indication prescribed for<\/span><\/td>\n<\/tr>\n
Typically covered by Medicare Part D?<\/b><\/td>\nNo<\/span><\/td>\nNot for weight loss<\/span><\/td>\n<\/tr>\n
Quantity<\/b><\/td>\nMonthly supply (five, 3 mL of 18 mg\/3 mL injector pens)<\/span><\/td>\nMonthly supply (four 0.75 mL of 2.4 mg\/0.75 mL injector pens)<\/span><\/td>\n<\/tr>\n
Average cost without insurance<\/b>*<\/span><\/td>\n$1,802.34<\/span><\/td>\n$1,810.46<\/span><\/td>\n<\/tr>\n
SingleCare cost<\/b>*<\/span><\/td>\n$1,190.00<\/span><\/td>\n$1,234.00 <\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*Prices subject to change<\/span><\/p>\n

Saxenda vs. Wegovy: Similarities<\/b><\/h2>\n

Saxenda and Wegovy are weight-loss drugs produced by drug manufacturer Novo Nordisk. Both Saxenda and Wegovy are self-administered through subcutaneous injections (under the skin). Both medications are in a class of medications called <\/span>glucagon-like peptide-1 receptor (GLP-1) agonists<\/span><\/a>. They function similarly in terms of regulating appetite and boosting feelings of fullness. <\/span><\/p>\n

For adults, Saxenda and Wegovy also share the same FDA criteria for use as a weight-loss medication:                     <\/span><\/p>\n